Actinogen Medical (ASX:ACW) Dividends per Share : A$0.00 (TTM As of Dec. 2023)

View and export this data going back to 2007. Start your Free Trial

What is Actinogen Medical Dividends per Share?

Actinogen Medical's dividends per share for the six months ended in Dec. 2023 was A$0.00. Its dividends per share for the trailing twelve months (TTM) ended in Dec. 2023 was A$0.00. Its Dividend Payout Ratio for the six months ended in Dec. 2023 was 0.00. As of today, Actinogen Medical's Dividend Yield % is 0.00%.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.

For more information regarding to dividend, please check our Dividend Page.

* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.

Actinogen Medical Dividends per Share Historical Data

The historical data trend for Actinogen Medical's Dividends per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Actinogen Medical Dividends per Share Chart

Actinogen Medical Annual Data

Trend

Jun14

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Jun24

Dividends per Share

Get a 7-Day Free Trial

Actinogen Medical Semi-Annual Data
	Jun14	Dec14	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Dividends per Share	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Actinogen Medical's Dividends per Share

For the Biotechnology subindustry, Actinogen Medical's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Actinogen Medical's Dividend Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Actinogen Medical's Dividend Yield % distribution charts can be found below:

* The bar in red indicates where Actinogen Medical's Dividend Yield % falls into.

Actinogen Medical Dividends per Share Calculation

Dividends paid to per common share.

Actinogen Medical (ASX:ACW) Dividends per Share Explanation

1. Dividend Payout Ratio measures the percentage of the company's earnings paid out as dividends.

Actinogen Medical's Dividend Payout Ratio for the quarter that ended in Dec. 2023 is calculated as

Dividend Payout Ratio	=	Dividends per Share (Q: Dec. 2023 )	/	EPS without NRI (Q: Dec. 2023 )
	=	0	/	-0.006
	=	N/A

2. Dividend Yield % measures how much a company pays out in dividends each year relative to its share price.

Actinogen Medical Dividends per Share Related Terms

Thank you for viewing the detailed overview of Actinogen Medical's Dividends per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Actinogen Medical Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Actinogen Medical Ltd (ASX:ACW) » Definitions » Dividends per Share

Comparable Companies

Traded in Other Exchanges

ATGGF:USA 3AC:Germany

Address

109 Pitt Street, Level 9, Suite 901, Sydney, NSW, AUS, 2000

Website

https://www.actinogen.com.au

Actinogen Medical Ltd is a biotechnology company. The company develops drugs for Alzheimer's disease and the cognitive decline associated with other neurological diseases. It is focused on the clinical development of Xanamem, an oral medication for neurological diseases amenable to its mechanism of lowering cortisol in brain cells. Geographically, the company's income is derived in Australia.

Actinogen Medical Headlines

From GuruFocus

Stocks That Are Making A Good Come Back

By reports.droy reports.droy • 03-10-2015

Accuride Corporation: Earnings Report For Q2 2014

By Black Iguana Nitish • 10-13-2014